Results 171 to 180 of about 934,404 (297)
Minimal residual disease in solid tumors: Clinical applications and future directions
Cancer, Volume 132, Issue 3, 1 February 2026.Abstract Minimal residual disease (MRD) refers to the presence of residual cancer cells or tumor‐derived fragments that persist after treatment and remain undetectable by conventional imaging or protein‐based assays. Circulating tumor DNA (ctDNA) has emerged as a dynamic biomarker for MRD detection.
Theresa Abdo +8 more
wiley +1 more source
IIB or not IIB, part 1: retrospective evaluation of Kenney–Doig categorization of equine endometrial biopsies at a veterinary diagnostic laboratory and comparison with published reports [PDF]
, 2021 Jane Westendorf +2 more
openalex +1 more source
Diagnostic Cytopathology, Volume 54, Issue 2, Page 71-77, February 2026.ABSTRACT Background Atypical glandular cells (AGC) in cervical cytology, as defined by the Bethesda System, indicate nuclear atypia beyond reactive changes but without definitive features of malignancy. Although clinically significant because it prompts follow‐up procedures, no quantitative threshold exists for AGC diagnosis.
Havva Gokce Terzioglu +2 more
wiley +1 more source
Radiogenomics: Current Understandings and Future Perspectives
MedComm, Volume 7, Issue 2, February 2026.Radiogenomics links imaging phenotypes with genetic variations, offering potential for comprehensive understanding, cost‐effective diagnosis, and prognosis prediction to advance personalized medicine. However, its clinical application remains limited by several challenges.
Xinyu Zhang +8 more
wiley +1 more source
IIB or not IIB, part 2: assessing inter-rater and intra-rater repeatability of the Kenney-Doig scale in equine endometrial biopsy evaluation. [PDF]
J Vet Diagn Invest, 2022 Westendorf J, Wobeser B, Epp T.
europepmc +1 more source
ZEB1 Expression in Endometrial Biopsy Predicts Lymph Node Metastases in Patient with Endometrial Cancer [PDF]
, 2014 Gang Feng +4 more
openalex +1 more source